Evidence map›Paper›PMID 22156346›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1.

Jessica E Morris, Stephanie Zobell, Xiao-Tang Yin, Hamideh Zakeri, Bretton C Summers, David A Leib, Patrick M Stuart

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. FAS mediates apoptosis, inflammation, and treatment of pathogen infection.Frontiers in cellular and infection microbiology · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Anti-IL-17 therapy restricts and reverses late-term corneal allorejection.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  16. Article
  17. Article
  18. CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.Journal of immunology (Baltimore, Md. : 1950) · 2014
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jessica E MorrisDepartment of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA.
Stephanie Zobell
Xiao-Tang Yin
Hamideh Zakeri
Bretton C Summers
David A Leib
Patrick M Stuart
Washington University in St. Louis · USSaint Louis University · US

Funding

VIRAL & HOST FACTORS IN HERPETIC REACTIVATIONR01EY009083 · NEI · WASHINGTON UNIVERSITY · PI David A Leib · 1992 to 2026
$10.3M
AMELIORATION OF RECURRENT HERPES KERATITISR01EY011885 · NEI · WASHINGTON UNIVERSITY · PI STUART, PATRICK M · 1998 to 2007
$2.3M
Mechanisms of HSK ameliorationR01EY021247 · NEI · SAINT LOUIS UNIVERSITY · PI STUART, PATRICK M · 2011 to 2014
$1.4M
THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMALR01EY016352 · NEI · SAINT LOUIS UNIVERSITY · PI STUART, PATRICK M · 2009 to 2010
$697k
NEI NIH HHS EY09083NEI NIH HHS EY11885NEI NIH HHS EY21247NEI NIH HHS R01 EY009083NEI NIH HHS R01 EY011885NEI NIH HHS R01 EY016352NEI NIH HHS R01 EY021247
6 · The paper itself

Abstract

HSV-1 infection of the cornea leads to a potentially blinding immunoinflammatory lesion of the cornea, termed herpetic stromal keratitis. It has also been shown that one of the factors limiting inflammation of the cornea is the presence of Fas ligand (FasL) on corneal epithelium and endothelium. In this study, the role played by FasL expression in the cornea following acute infection with HSV-1 was determined. Both BALB/c and C57BL/6 (B6) mice with HSV-1 infection were compared with their lpr and gld counterparts. Results indicated that mice bearing mutations in the Fas Ag (lpr) displayed the most severe disease, whereas the FasL-defective gld mouse displayed an intermediate phenotype. It was further demonstrated that increased disease was due to lack of Fas expression on bone marrow-derived cells. Of interest, although virus persisted slightly longer in the corneas of mice bearing lpr and gld mutations, the persistence of infectious virus in the trigeminal ganglia was the same for all strains infected. Further, B6 mice bearing lpr and gld mutations were also more resistant to virus-induced mortality than were wild-type B6 mice. Thus, neither disease nor mortality correlated with viral replication in these mice. Collectively, the findings indicate that the presence of FasL on the cornea restricts the entry of Fas(+) bone marrow-derived inflammatory cells and thus reduces the severity of HSK.

Indexed as

Genetic Predisposition to DiseaseAnimalsBone Marrow TransplantationDisease ResistanceFas Ligand Proteinfas ReceptorGene Expression Regulation, ViralHerpesvirus 1, HumanInflammationKeratitis, HerpeticMiceMice, Inbred BALB CMice, Inbred C57BLMice, Mutant StrainsRadiation ChimeraSeverity of Illness IndexFas Ligand ProteinFasl protein, mousefas Receptor

Identifiers

PMID22156346
PMCPMC3253206
OpenAlexW2137807963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.